Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.

@article{Laar2005AlphaglucosidaseIF,
  title={Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.},
  author={Floris van de Laar and Peter Lbj Lucassen and Reinier Akkermans and Eloy van de Lisdonk and Guy E.H.M. Rutten and Chris van Weel},
  journal={Diabetes care},
  year={2005},
  volume={28 1},
  pages={
          154-63
        }
}
OBJECTIVE To review the effects of monotherapy with alpha-glucosidase inhibitors (AGIs) for patients with type 2 diabetes, with respect to mortality, morbidity, glycemic control, insulin levels, plasma lipids, body weight, and side effects. RESEARCH DESIGN AND METHODS We systematically searched the Cochrane Central register of Controlled Trials, MEDLINE, EMBASE, Current Contents, LILACS, databases of ongoing trials, and reference lists, and we contacted experts and manufacturers. Inclusion… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 134 CITATIONS

Similar Papers

Loading similar papers…